FORE BIOTHERAPEUTICS
We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
FORE BIOTHERAPEUTICS
Industry:
Biotechnology Health Care Health Diagnostics Life Science Medical Personal Health
Founded:
2011-01-01
Address:
Jerusalem, Yerushalayim, Israel
Country:
Israel
Website Url:
http://www.fore.bio
Total Employee:
11+
Status:
Active
Contact:
972 2 500 1100
Total Funding:
91.5 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Google Maps Google Google Maps API Google Cloud Amazon Route 53 Amazon S3
Similar Organizations
Haodf.com
Haodf.com Provides Internet Medical Platforms.
Metabolomic Diagnostics
Metabolomic Diagnostics specializes in the development of novel biomarker based diagnostic solutions for complex diseases
ORIG3N
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.
Current Advisors List
Board_member
Board_member
2020-07-01
Current Employees Featured
Gabi Tarcic Chief Technology Officer @ Fore Biotherapeutics
Chief Technology Officer
Stacie Shepherd CMO @ Fore Biotherapeutics
CMO
Matthew Ros Chief Executive Officer @ Fore Biotherapeutics
Chief Executive Officer
2022-04-01
Nora E Brennan Chief Financial Officer @ Fore Biotherapeutics
Chief Financial Officer
Michael Vidne Chief Business & Strategy Officer @ Fore Biotherapeutics
Chief Business & Strategy Officer
Founder
Investors List
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series C - Fore Biotherapeutics
HBM Partners
HBM Partners investment in Series C - Fore Biotherapeutics
Novartis Venture Fund
Novartis Venture Fund investment in Series C - Fore Biotherapeutics
Pontifax
Pontifax investment in Series C - Fore Biotherapeutics
OrbiMed
OrbiMed investment in Series C - Fore Biotherapeutics
Wellington Management
Wellington Management investment in Series C - Fore Biotherapeutics
SR One
SR One investment in Series C - Fore Biotherapeutics
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series C - Fore Biotherapeutics
Cormorant Asset Management
Cormorant Asset Management investment in Series C - Fore Biotherapeutics
3B Future Health Fund
3B Future Health Fund investment in Venture Round - Fore Biotherapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-04-18 | Fore Biotherapeutics Appoints Matthew E. Ros as Chief Executive Officer |
Official Site Inspections
http://www.fore.bio Semrush global rank: 6.48 M Semrush visits lastest month: 970
- Host name: 151.101.2.159
- IP address: 151.101.2.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Fore Biotherapeutics"
About Us - Fore Biotherapeutics
Fore Bio is a next-generation precision oncology company. Using our functional genomics platform, we are hyper-targeting therapies to unaddressed tumor mutations to benefit patients with few therapeutic alternatives. Our mission is …See details»
Company - Fore Biotherapeutics
Investors Fore is backed by top investors with deep industry knowledge and a successful history of forming some of the world’s leading oncology companies. Read more About Us We are a …See details»
Fore Biotherapeutics - Crunchbase Company Profile
Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics. The company is creating a pipeline …See details»
Fore Biotherapeutics Inc. Company Profile | Philadelphia, PA ...
Find company research, competitor information, contact details & financial data for Fore Biotherapeutics Inc. of Philadelphia, PA. Get the latest business insights from Dun & Bradstreet.See details»
Fore Biotherapeutics - Israeli Startup | Startup Nation …
Feb 23, 2023 Fore Biotherapeutics is a precision oncology company using functional genomics to pioneer treatments that improve the lives of patients with rare cancers. Using its functional genomics platform, the company is hyper …See details»
Fore Biotherapeutics 2025 Company Profile: Valuation, …
Fore Biotherapeutics was founded in 2011. Where is Fore Biotherapeutics headquartered? Fore Biotherapeutics is headquartered in Philadelphia, PA. What is the size of Fore Biotherapeutics? Fore Biotherapeutics has 45 total …See details»
Fore Bio lands in Philadelphia - PharmaLive
Jun 15, 2021 Fore’s location in Philadelphia puts the organization in proximity to global financial leaders in New York City and an esteemed base of potential strategic partners in New Jersey and Washington, D.C. Med Ad News: Please …See details»
Fore Biotherapeutics - VentureRadar
"We are a precision oncology company pioneering the development of cancer therapies guided by functional genomics. We develop treatments for patients with genetically defined cancers, …See details»
A Brief History of Fore Biotherapeutics – CanvasBusinessModel.com
Dec 5, 2024 A Brief History of Fore Biotherapeutics - The field of biotherapeutics has seen significant advancements in recent years, with Fore Biotherapeutics at the forefront of …See details»
Fore Biotherapeutics Opens U.S. Headquarters in Philadelphia’s …
May 10, 2021 Fore’s lead asset, FORE8394, is a Class I/II BRAF inhibitor for RAS-mutant cancers and is currently being evaluated in a Phase 1 dose-finding study. The company plans …See details»
Leadership - Fore Biotherapeutics
Fore Biotherapeutics honors the memory of those who provided outstanding service to the organization as an advisor to the company. Interested in joining us? Check out our open roles. …See details»
Fore Biotherapeutics Continues to Build Leadership Team with …
Sep 20, 2021 Fore Bio Contact: Nora Brennan media@Fore.Bio. Media Contact: Gwendolyn Schanker LifeSci Communications gschanker@lifescicomms.com +1 269 921 3607 Release …See details»
Pharma's Almanac: Nice Insight's Content Community
Fore Bio is a precision oncology company initiating the development of cancer therapies guided by proprietary functional genomics. The company's main goal is to compassionately contribute …See details»
Mission, Vision & Core Values of Fore Biotherapeutics
Dec 5, 2024 Fore Biotherapeutics is dedicated to revolutionizing the field of biotechnology with innovative treatments and therapies. Our mission is to improve the lives of patients worldwide …See details»
Fore Biotherapeutics, Inc. - Drug pipelines, Patents ... - Patsnap
Explore Fore Biotherapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 8 clinical trials, 42 news, and 3 literature, Disease Domain:Hemic ...See details»
FORE Awards $2.1 Million to Four Organizations Pursuing …
2 days ago FORE today announced four new awards, totaling $2.1 million, to organizations that are addressing systemic barriers to effective treatment and recovery — including workforce …See details»
Fore Biotherapeutics - Overview, News & Similar companies
Aug 11, 2024 Michael Byrnes has joined the organization as Chief Financial Officer. Previously, Byrnes served as Chief Financial Officer for eFFECTOR. Executive Moves, New Hire ... (267) …See details»
FORE Biotherapeutics Highlights Recent Pipeline Achievements for …
Jan 9, 2025 Fore is a registration stage targeted oncology company dedicated to developing innovative treatments that provide better outcomes for patients with the hardest-to-treat …See details»
Drugmakers sound alarm on possible Trump tariff impacts
2 days ago Digging deeper into the BIO survey results, 94% of companies polled said they expect tariffs on the EU to drive up manufacturing costs. Meanwhile, 82% of respondents …See details»
New survey: U.S. biotechs warn tariffs could impede access to …
3 days ago WASHINGTON (March 26, 2025) -- Today, the Biotechnology Innovation Organization (BIO) released results from a membership survey that underscores the …See details»